Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option

Huaqing Yang; Weidong Han; Hui Li

doi:10.36721/PJPS.2020.33.3.SP.1349-1354.1

original articles

Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option

Huaqing Yang, Weidong Han, Hui Li

Vol. 33

Issue 3

Pages 1349-1354

Published 01 May 2020

DOI: 10.36721/PJPS.2020.33.3.SP.1349-1354.1

Authors Abstract Related

Authors & Affiliations

Huaqing Yang

Weidong Han

Hui Li

Abstract

This pilot study designed to evaluate the efficacy and safety of MAO-B inhibitor in comparison with Donepezil

Keywords

Selective MAO-B inhibitor

donepezil

post-stroke cognitive impairment

selegiline

Metrics

PlumX Metrics

original articles

Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option

Huaqing Yang, Weidong Han, Hui Li

Vol. 33

Issue 3

Pages 1349-1354

Published 01 May 2020

DOI: 10.36721/PJPS.2020.33.3.SP.1349-1354.1

Authors Abstract Related

Authors & Affiliations

Huaqing Yang

Weidong Han

Hui Li

Abstract

This pilot study designed to evaluate the efficacy and safety of MAO-B inhibitor in comparison with Donepezil

Keywords

Selective MAO-B inhibitor

donepezil

post-stroke cognitive impairment

selegiline

Metrics

PlumX Metrics

Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Efficacy and safety of MAO-B inhibitor versus donepezil in Chinese elderly stroke patients with Alzheimer disease: A potential therapeutic option

Authors & Affiliations

Abstract

Keywords

Metrics